Skip to main content
. 2022 Sep 9;101(36):e30347. doi: 10.1097/MD.0000000000030347

Figure 12.

Figure 12.

Forest plot of ARR comparison between patients with AQP-4 positive and negative NMO treated with rituximab. ARR = annualized relapse rate, AQP-4 = anti-aquapor in-4-antibody, NMO = neuromyelitis optica.